Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

NCT04428424 ·Status: COMPLETED

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

NCT04267614 ·Status: COMPLETED

Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation

NCT04393233 ·Status: COMPLETED

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

NCT01981473 ·Status: COMPLETED

Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis

NCT03574545 ·Status: COMPLETED ·Phase: PHASE1

Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

NCT01328522 ·Status: COMPLETED ·Phase: PHASE1

Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs

NCT04139954 ·Status: UNKNOWN

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)

NCT02094326 ·Status: COMPLETED

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

NCT00484237 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

NCT00293709 ·Status: COMPLETED

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

NCT01787149 ·Status: UNKNOWN ·Phase: PHASE3

Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis

NCT03599986 ·Status: COMPLETED

Rheumatoid Arthritis DMARD Intervention and UtilizationStudy

NCT00116727 ·Status: COMPLETED

Information and Acceptability of Biosimilars

NCT04321291 ·Status: UNKNOWN ·Phase: NA

Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient

NCT01724268 ·Status: UNKNOWN ·Phase: PHASE3

Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan

NCT00888576 ·Status: COMPLETED

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

NCT04507763 ·Status: COMPLETED

Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

NCT00195377 ·Status: COMPLETED

Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases

NCT04353609 ·Status: COMPLETED

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

NCT00953979 ·Status: COMPLETED ·Phase: PHASE4

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

NCT00110903 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

NCT00296894 ·Status: COMPLETED ·Phase: PHASE2